What happened
Pulmuone Corporate reported a subsidiary's separate results for FY2025: revenue of US$63.7M (+0.05% year on year), operating profit of US$1.65M (−63.82% year on year) and net income of US$2.35M (−53.84% year on year).
Korean rules require this filing when revenue or profit moves 30% or more from the prior year (15% for large companies). The figures are the company's own and may not be audited yet.
| Revenue | US$63.7M |
|---|---|
| Revenue vs a year earlier | +0.05% |
| Operating profit | US$1.65M |
| Net income | US$2.35M |
| Period | FY2025 (separate) |
| Filed | 2026-02-03, Change of 30% or more in revenue or profit/loss structure (15% for large companies) (subsidiary) |
| Source | DART rcept 20260203800063 → open original filing |
Source: DART. Information only, not investment advice.